Clinical research has indicated that FOXO4-DRI has shown promise in the following areas: Targets senescent cells FOXO4-DRI is a synthetic peptide designed to target senescent cells, which are damaged cells that stop dividing but resist apoptosis (programmed cell death)
Over time, this can weaken the integrity of existing strands while impeding new growth
Discover the cutting-edge technology and expert care behind every service we offer
Composed of 15 amino acids (Gly-Glu-Ser-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu), it is renowned for its exceptional molecular stability, particularly its resistance to enzymatic degradation in various physiological environments
As a research reagent, MOTS-c shows no systemic side effects but must be handled under standard lab-safety protocols
Healthletics BPC-157 may be of interest to those looking to support ligament, tendon, and muscle resilience